INTRODUCTION
Next generation sequencing technologies have unlocked a new era of human genome sequencing. Human genomes are being sequenced at unprecedented rates (1 -9) , and the age of personalized medicine is rapidly approaching. In the near future, an individual's genome will be sequenced to predict the future health of the individual and to develop personalized medical treatments that are tailored to work with the genetic variation that is detected. Variation profiles also will be used to predict a host of other human traits including height, weight, appearance, lifespan and intelligence. Genome-wide association studies (GWASs) have already begun to identify the predictive variants that are necessary for this enterprise, and many additional variants will be identified. Ultimately, personal genomes will be compared with databases of informative variants, genes and biological pathways to make predictions about human traits and diseases.
To fulfill this vision, it will be necessary to routinely detect all of the genetic variation that is present in a given human genome. This includes: (i) single nucleotide polymorphisms [SNPs (10) (11) (12) ], (ii) small insertions and deletions (INDELs) ranging from 1 to 10 000 bp in length (13) (14) (15) and (iii) larger forms of structural variation (16) (17) (18) (19) (20) (21) (22) . In this review, we focus on progress that has been made with detecting small INDELs in human genomes. Despite the fact that small INDELs are highly abundant in humans and cause a great deal of variation in human genes, they have received far less attention than SNPs and larger forms of structural variation. Small INDELs have been particularly challenging to detect, validate and genotype, and customized tools have been necessary to study this class of variation. Moving forward, new technologies will be needed to evaluate the impact of these INDELs on human traits and diseases.
INDEL VARIATION ON HUMAN CHROMOSOME 22
The first large-scale efforts to identify INDELs in the human genome were focused on human chromosome 22 (23, 24 (10-12)]. In a follow-up study, almost two million non-redundant INDELs were identified from DNA re-sequencing data (R.E. Mills et al., submitted for publication). The INDELs that were discovered ranged from 1 to 10 000 bp in length, and were distributed throughout the human genome on all 24 chromosomes. Several classes of INDELs were identified, including repeat expansions, transposon insertions and random sequences. PCR-based validation studies indicated that the Mills et al. (15) pipeline has an accuracy of 97%.
Kidd et al. (22) also reported 796 273 small INDELs in a project that was designed to detect structural variation in eight diverse humans (Table 1 ). In addition to the structural variants that were detected in fosmids by paired-end sequencing, SNPs and small INDELs also were discovered from the ABI traces that were generated. (3) . It seems unlikely that INDEL variation is genuinely this different among three humans. The INDELs discovered in the Venter genome ranged from 1 to 82 711 bp in length (1), whereas those discovered in the Han Chinese genome were limited to 1 -3 bp in length (3). Thus, some of these differences appear to be due to differences in INDEL discovery among these projects. The sequencing platforms and analysis approaches that were employed also were quite variable. For example, the Venter genome was sequenced with traditional ABI reads (1), the Watson genome was sequenced with 454 reads (2) and the Han Chinese genome was sequenced with Illumina reads (3). The validation rates for these approaches also varied considerably. In most cases, very few INDELs were evaluated in validation studies, and in many cases, only a small subset was examined. For example, although 342 965 small INDELs were reported in
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Human Molecular Genetics, 2010, Vol. (27) , ELAND (Illumina) and MAQ (28) have been used extensively for trace mapping and variation discovery in Illumina-based personal genome projects (Table 2) . Several other approaches also have been developed (29) (30) (31) (32) , and most of these approaches have INDEL detection capabilities (Table 2) . Although all of these approaches initially attempt to map either the whole trace or a segment of the trace to the reference genome, accurate mapping is often limited by the presence of INDELs [particularly if they are larger than 1 -3 bp (27 -32)]. In some cases, sequence reads that initially do not map well to the genome are re-mapped and aligned using programs that can support gapped or splitread alignments (30) . Paired-end reads also are used to detect INDELs: one read serves to map the pair of reads, whereas the second read is subjected to gapped alignments and INDEL detection (28) (29) (30) . In this instance, the first read is not allowed to vary as much as the second read, and variation is undoubtedly missed when both reads contain INDELs. In other cases, all traces are mapped and aligned to the genome using algorithms that perform gapped alignments (29, 32) . Although simulation studies suggest that several of these methods have high levels of sensitivity, the false negative rates for these approaches range from 10 to 35% (Table 2) . Thus, up to a third of the small INDELs in personal genomes are being missed with these approaches.
FUNCTIONALLY IMPORTANT INDELS
Like SNPs and structural variation, INDELs are of great interest because they can alter human traits and can cause human diseases. One of the most common genetic diseases in humans, cystic fibrosis, is frequently caused by a coding INDEL polymorphism within the CFTR gene that eliminates a single amino acid (33) . The Mills et al. (15) study described above revealed that coding INDELs are prevalent in human populations. A total of 262 coding INDELs were identified in the 36 healthy humans that were examined. More than half of these coding INDELs (160/262 or 61.1%) were multiples of 3 bp, and thus, maintained the open reading frames of the proteins. In some of these cases, amino acid(s) would be precisely inserted or deleted. However, in other cases (when an in-frame INDEL does not coincide perfectly with codon boundaries), additional amino acid changes may also occur in the region that is altered. The remaining INDELs from the Mills et al. study (102/262 or 38.9%) were not multiples of 3 bp and thus caused frame shifts in the encoded proteins. This class of INDELs generally would be expected to The pipeline that was developed and tested above (15) was used in this study. (Table 1) . Exome re-sequencing projects likewise have identified a large number of coding INDELs in typical humans (35) , suggesting that most, if not all humans, carry a substantial genetic load of coding INDELs. Thus, coding INDELs are likely to have a major impact on human biology and diseases.
INDELs that occur in other functionally important regions of genes also could be envisioned to affect gene function. For example, DNA insertions within the promoter region of the FMR1 gene cause Fragile X syndrome in humans (36) . Once the trinucleotide expansion reaches a critical size threshold, the methylation patterns of the promoter are altered, leading to changes in FMR1 gene expression. Mills et al. (15) identified 3829 small INDELs that map to the promoter regions of RefSeq genes. In addition to repeat expansions as outlined for FMR1, INDELs that occur within transcription factor binding sites or enhancers also could be envisioned to diminish or abolish gene expression. INDELs also have the capacity to dramatically alter the phasing and spacing of DNA sequences within promoters. For example, a 5 bp INDEL could rotate a transcription factor binding site to the opposite face of the DNA helix, and a 100 bp INDEL could increase the spacing between two binding sites such that productive interactions are disrupted. Thus, INDELs within gene promoter regions might help explain the differences in gene expression that have been observed in diverse humans (37) .
ENDOGENOUS RETROTRANSPOSONS CAUSE SMALL INDELS IN HUMAN GENOMES
Mobile genetic elements produce a great deal of small INDEL variation in humans (38, 39) . In particular, active Alu, L1 and SVA retrotransposons continue to produce new insertions when they 'jump' from one place to another in the human genome (38, 39) . When they jump, Alu elements cause new insertions of 300 bp, whereas L1 and SVA elements cause insertions that range from tens of base pairs in length up to 3 kb (SVA) or 6 kb (L1) in length (38) . Recent studies indicate that Alu and L1 elements produce millions of new insertions worldwide in human populations (40 -45) . New insertions, by definition, cause rare insertion alleles because they initially occur in only a single human. Many of these new insertions occur in human genes (including the exons of these genes) and such insertions can affect gene function (38, 40) . The fulllength source elements that produce new L1 insertions are themselves highly variable among diverse humans, suggesting that some genomes might produce more new L1 insertions than others (41) . Nevertheless, endogenous retrotransposons appear to cause rare insertion alleles in most, if not all, human genomes and these insertions can influence human biology (38, 40) .
THE FUTURE OF INDEL DISCOVERY IN PERSONAL HUMAN GENOMES
Moving forward, there are several major questions. First, exactly how many small INDELs are present in the average human genome? And how does this number differ from one human to the next? The numbers that have been reported thus far are quite variable (Table 1 ). It appears that variability in INDEL discovery is at the root of these differences rather than true differences in the number of INDELs. Genuine differences between two individuals might be of great interest. Do some genomes actually carry fewer INDELs than others? To answer these questions, it will be necessary to define a standardized size range for INDEL discovery that will be applied to all genomes (1 to 100 bp? 1 to 10 000 bp?). In this regard, it might be useful to compare two or more of the genomes that have already been sequenced (Table 1) And the biggest question of all: which small INDELs affect human traits and diseases and how will we find these INDELs? Several experimental approaches could be taken to answer this question. First, the small INDELs that have been discovered thus far (Table 1 ; totaling several million in dbSNP) could be genotyped and integrated into the human HapMap in the same way that SNPs were genotyped for the HapMap (10 -12) . Common INDELs that map to exons, promoters and other functionally important sites could be given the 
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Human Molecular Genetics, 2010, Vol. 19, Review Issue 2 highest priority. Once integrated into the HapMap, these INDELs would greatly expand the number of high-scoring variants that are identified in GWASs. As efforts turn to whole genome re-sequencing as an approach for identifying causative variants, it will become even more critical to detect INDELs fully and accurately. The biggest and perhaps most interesting challenge ahead will be to develop a comprehensive framework of variants, genes and biological pathways that can be used to predict human health.
